Eterna Therapeutics Stock Price on December 14, 2024
| ERNA Stock | USD 0.29 0.01 3.57% |
If you're considering investing in Eterna Stock, it is important to understand the factors that can impact its price. As of today, the current price of Eterna Therapeutics stands at 0.29, as last reported on the 4th of March, with the highest price reaching 0.29 and the lowest price hitting 0.26 during the day. Eterna Therapeutics appears to be out of control, given 3 months investment horizon. Eterna Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0326, which denotes the company had a 0.0326 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Eterna Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Eterna Therapeutics' Coefficient Of Variation of 3063.02, downside deviation of 8.73, and Mean Deviation of 7.76 to check if our risk estimates are consistent with your expectations.
Eterna Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Eterna |
Sharpe Ratio = 0.0326
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ERNA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.88 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Eterna Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eterna Therapeutics by adding it to a well-diversified portfolio.
Related Headline
Acumen Pharmaceuticals Headline on 13th of December 2024
Acquisition by Stalfort John A Iii of 25000 shares of Acumen... by MacroaxisInsider
Filed transaction by Acumen Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3
Eterna Therapeutics Valuation on December 14, 2024
It is possible to determine the worth of Eterna Therapeutics on a given historical date. On December 14, 2024 Eterna was worth 0.28 at the beginning of the trading date compared to the closed value of 0.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eterna Therapeutics stock. Still, in general, we apply an absolute valuation method to find Eterna Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eterna Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eterna Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.30 | 0.33 | 0.28 | 0.29 | 407,800 | |
12/13/2024 | 0.28 | 0.32 | 0.28 | 0.29 | 299,500 |
| 0.30 | 0.30 | 0.27 | 0.27 | 743,000 |
| Backtest Eterna Therapeutics | | | Eterna Therapeutics History | | | Eterna Therapeutics Valuation | Previous | Next |
Eterna Therapeutics Trading Date Momentum on December 14, 2024
| On December 16 2024 Eterna Therapeutics was traded for 0.27 at the closing time. The top price for the day was 0.30 and the lowest listed price was 0.27 . The trading volume for the day was 743 K. The trading history from December 16, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 6.90% . The overall trading delta against the current closing price is 13.79% . |
Eterna Therapeutics Fundamentals Correlations and Trends
By evaluating Eterna Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eterna Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eterna financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Eterna Therapeutics Stock history
Eterna Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eterna is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eterna Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eterna Therapeutics stock prices may prove useful in developing a viable investing in Eterna Therapeutics
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York. Eterna Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Eterna Therapeutics Stock Technical Analysis
Eterna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Eterna Therapeutics Period Price Range
Low | March 4, 2025
| High |
0.00 | 0.00 |
Eterna Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Eterna Therapeutics March 4, 2025 Market Strength
Market strength indicators help investors to evaluate how Eterna Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eterna Therapeutics shares will generate the highest return on investment. By undertsting and applying Eterna Therapeutics stock market strength indicators, traders can identify Eterna Therapeutics entry and exit signals to maximize returns
Eterna Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eterna Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Eterna Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eterna to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0344 | |||
| Jensen Alpha | 0.449 | |||
| Total Risk Alpha | 1.74 | |||
| Sortino Ratio | 0.0534 | |||
| Treynor Ratio | 0.4677 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Eterna Stock analysis
When running Eterna Therapeutics' price analysis, check to measure Eterna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eterna Therapeutics is operating at the current time. Most of Eterna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Eterna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eterna Therapeutics' price. Additionally, you may evaluate how the addition of Eterna Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |